100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Samenvatting van het volledige vak farmacologie dus zowel partim I & II (behaald resultaat 19/20) $8.03
Add to cart

Summary

Samenvatting van het volledige vak farmacologie dus zowel partim I & II (behaald resultaat 19/20)

 26 views  0 purchase
  • Course
  • Institution

Samenvatting van het volledige vak farmacologie dus zowel partim I & II (behaald resultaat 19/20): Dit bevat een uitgebreide samenvatting van Farmacologie gegeven door professor Pieter-Jan Guns & professor Guido De Meyer. De samenvatting bevat al de lessen (deel 1 & 2), informatie uit de cursus en ...

[Show more]

Preview 4 out of 117  pages

  • September 27, 2022
  • 117
  • 2020/2021
  • Summary
avatar-seller
Farmacologie
3E BACH GEN
2016-2017

,Inhoud
1 Farmacodynamiek...............................................................................................................................1
1.1 Receptoren...................................................................................................................................1
1.2 Geneesmiddelen en signaaltransductie........................................................................................1
1.3 Farmacon-receptor interacties.....................................................................................................2
1.4 Adaptatie en therapeutische index...............................................................................................4
2 Farmacokinetiek & Geneesmiddelendispositie....................................................................................5
2.1 Farmacokinetiek...........................................................................................................................5
2.2 Passage door celmembranen........................................................................................................7
2.3 Absorptie – resorptie....................................................................................................................8
2.4 Distributie...................................................................................................................................10
2.5 Eliminatie....................................................................................................................................11
3 Individuele variaties en interacties....................................................................................................14
3.1 Idiosyncratische reactie..............................................................................................................14
3.2 Leeftijd........................................................................................................................................14
3.3 Genetische factoren...................................................................................................................14
3.4 Ziekte..........................................................................................................................................14
3.5 Geneesmiddeleninteracties........................................................................................................15
4 Chemische transmissie en het AZS....................................................................................................17
4.1 Presynaptische modulatie...........................................................................................................17
4.2 Co-transmitters...........................................................................................................................17
4.3 Denervatie supersensitiviteit......................................................................................................17
4.4 Basisstappen in de neurochemische transmissie........................................................................18
4.5 Belangrijke figuren......................................................................................................................19
5 Cholinerge transmissie......................................................................................................................20
5.1 Muscarine en nicotine effecten van ACh....................................................................................20
5.2 Muscarine receptor agonisten....................................................................................................21
5.3 Muscarine receptor antagonisten...............................................................................................22
5.4 Nicotine receptoren....................................................................................................................23
5.5 Potentiëring cholinerge transmissie: cholinesteraseremmers....................................................25
6 Adrenerge neurotransmissie.............................................................................................................28
6.1 Classificatie adrenerge receptoren.............................................................................................28
6.2 Adrenerge receptor agonisten....................................................................................................29
6.3 Α--adrenoceptor antagonisten...................................................................................................31
6.4 Beta-adrenerge antagonisten.....................................................................................................31
6.5 Fysiologie vd adrenerge neurotransmissie.................................................................................32
6.6 Indirect werkende sympathicomimetica....................................................................................33

I

,7 5-Hydroxytryptamine (Serotonine)....................................................................................................35
7.1 Distributie, biosynthese en metabolisme...................................................................................35
7.2 Effecten en functies....................................................................................................................35
7.3 Receptoren.................................................................................................................................36
7.4 Ergotalkaloïden...........................................................................................................................36
8 Purines...............................................................................................................................................38
8.1 ATP & ADP..................................................................................................................................38
8.2 Adenosine...................................................................................................................................38
9 Stikstofoxide......................................................................................................................................39
9.1 Synthese, inactivatie en transport..............................................................................................39
9.2 Effecten.......................................................................................................................................39
9.3 Rol in pathologie.........................................................................................................................39
9.4 Klinische toepassingen................................................................................................................40
10 Lokale hormonen, ontsteking en allergie........................................................................................41
10.1 Histamine..................................................................................................................................41
10.2 Prostaglandinen........................................................................................................................43
10.3 Leukotriënen.............................................................................................................................45
10.4 Bradykinine...............................................................................................................................46
11 Anti-inflammatoire en immunosuppressieve farmaca....................................................................47
11.1 NSAID........................................................................................................................................47
11.2 Glucocorticoïden.......................................................................................................................49
11.3 Antirheumatica (DMARD’s).......................................................................................................52
11.4 Immunosuppressiva..................................................................................................................52
11.5 Anti-jichtmiddelen....................................................................................................................53
12 Hemostase en trombose..................................................................................................................54
12.1 Inleiding....................................................................................................................................54
12.2 Trombocyten............................................................................................................................55
12.3 Antiplaatjesmiddelen................................................................................................................55
12.4 Stollingscascade........................................................................................................................57
12.5 Anti-Stollings GM......................................................................................................................58
12.6 Fibrinolytica..............................................................................................................................60
12.7 Samenvatting GM.....................................................................................................................61
13 Hypolipemiërende farmaca.............................................................................................................63
13.1 Lipoproteïnetransport in het bloed..........................................................................................63
13.2 Atherogenese...........................................................................................................................63
13.3 Hypolipemiërende farmaca......................................................................................................64
14 Hart..................................................................................................................................................67
14.1 Farmaca die hartfunctie beïnvloeden.......................................................................................67

II

, 14.2 Anti-aritmica.............................................................................................................................67
14.3 Inotrope stoffen........................................................................................................................70
14.4 Autonome transmitters en verwante stoffen...........................................................................72
14.5 Anti-anginosa............................................................................................................................72
15 Vasculair systeem............................................................................................................................76
15.1 Contractie en relaxatie van GSC................................................................................................76
15.2 Vasoconstrictoren.....................................................................................................................77
15.3 Vasodilatoren............................................................................................................................78
15.4 Klinische toepassing van vasoactieve GM.................................................................................78
15.5 Nevenwerkingen antihypertensiva...........................................................................................80
16 Diuretica..........................................................................................................................................82
16.1 Functie niertubuli......................................................................................................................82
16.2 Diuretica...................................................................................................................................82
17 Ademhalingsstelsel..........................................................................................................................85
17.1 Regulatie musculatuur, bloedvaten en klieren.........................................................................85
17.2 Farmaca die ademhaling beïnvloeden......................................................................................85
17.3 Bronchiaal astma......................................................................................................................85
18 Maagdarmstelsel.............................................................................................................................88
18.1 Secretie maagzuur, mucus en bicarbonaat...............................................................................88
18.2 Antacida....................................................................................................................................88
18.3 Maagzuursecretie inhibitoren...................................................................................................89
18.4 Behandeling H.pylori................................................................................................................89
18.5 Anti-emetica.............................................................................................................................90
18.6 Laxativa.....................................................................................................................................91
18.7 Antidiarreïca.............................................................................................................................92
18.8 Spasmolytica.............................................................................................................................92
19 Chemische transmissie en werking van GM in CZS..........................................................................93
19.1 Chemische transmissie in CZS...................................................................................................93
19.2 Werking van GM in CZS.............................................................................................................93
19.3 Classificatie psychotrope GM....................................................................................................93
20 AZ als NT..........................................................................................................................................94
20.1 Exciterende AZ..........................................................................................................................94
20.2 Inhiberende AZ.........................................................................................................................94
21 Andere NT en modulatoren in CZS..................................................................................................96
21.1 Noradrenaline...........................................................................................................................96
21.2 Dopamine.................................................................................................................................96
21.3 Serotonine................................................................................................................................97
21.4 ACh...........................................................................................................................................97

III

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller lemmeslodders. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $8.03. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

49497 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$8.03
  • (0)
Add to cart
Added